|
Volumn 3, Issue 6, 1998, Pages 250-256
|
Novel molecular targets for the treatment of obesity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID;
ALPHA INTERMEDIN;
ANTIOBESITY AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BIOGENIC AMINE;
BMS 187257;
CYCLOHEXYL[4 [2 [2 HYDROXY 3 (4 HYDROXYPHENOXY)PROPYLAMINO]ETHYL]PHENOXYMETHYL]PHOSPHINIC ACID;
FR 165914;
GALANIN;
GR 23118;
HEXYLUREA;
LEPTIN;
LY 357897;
MELANOCORTIN;
N [1 [4 [[[[4 [(DIMETHYLAMINO)METHYL]CYCLOHEXYL]METHYL]AMINO]IMINOMETHYL]BENZYL] 2 OXO 2 (1 PYRROLIDINYL)ETHYL] ALPHA [(2 NAPHTHALENYLSULFONYL)AMINO]BENZENEPROPANAMIDE;
NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE;
NEUROGEN;
PD 160170;
SR 5811A;
UNCLASSIFIED DRUG;
APPETITE;
CALORIC INTAKE;
DRUG EFFECT;
DRUG RECEPTOR BINDING;
DRUG TARGETING;
ENERGY BALANCE;
ENERGY EXPENDITURE;
HUMAN;
NEUROTRANSMISSION;
OBESITY;
REVIEW;
THERMOGENESIS;
WEIGHT REDUCTION;
|
EID: 0031803273
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(98)01189-1 Document Type: Review |
Times cited : (21)
|
References (64)
|